Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.

Older adults vaccinated against herpes zoster, or shingles, had a reduced risk of developing dementia, over a period of 7 years.

Patients with atopic dermatitis had an increased risk for COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.

The occurrence of JHR after benzathine penicillin G treatment for early syphilis was positively associated with secondary syphilis and negatively associated with lack of HIV.

Bacille Calmette-Guérin revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection.

Sustainable development strategies are important for helping countries to address climate change and antimicrobial resistance.

Apixaban showed superior safety and lower risk for major bleeding than both warfarin and rivaroxaban among older adult patients with HIV and AF.

The European Union is looking to capitalize on the Trump administration's dismantling of US research programs to beef up its own.

Ceftazidime-avibactam and ceftolozane-tazobactam were the most commonly prescribed antibiotics of all broad-spectrum agents approved in the past decade.